Robert James Wills

Insider Reports History

Location
Spring Lake, NJ
Signature
/s/ Robert James Wills
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert James Wills:

Company Role Class Num Shares Value Price $ Report Date Ownership
Alpha Cognition Inc. Director Common Shares 22,241 $144,566 $6.50 14 Jan 2026 Direct
Oncternal Therapeutics, Inc. Director Common Stock 10,000 $89,613 $8.96 08 Apr 2024 Direct
Milestone Pharmaceuticals Inc. Director Common Shares 65,000 $78,000 $1.20 11 Jul 2025 Direct
CymaBay Therapeutics, Inc. Director Common Stock 0 $0 $2.94 22 Mar 2024 Direct
Milestone Pharmaceuticals Inc. Director Series A Common Warrants (right to buy) 50,000 11 Jul 2025 Direct
Milestone Pharmaceuticals Inc. Director Series B Common Warrants (right to buy) 50,000 11 Jul 2025 Direct
Milestone Pharmaceuticals Inc. Director Stock Option (right to buy) 40,000 10 Jun 2025 Direct
Alpha Cognition Inc. Director Director Stock Option (Right to Buy) 30,019 07 Apr 2025 Direct
Alpha Cognition Inc. Director Common Share Options 8,437 14 Jan 2026 Direct
Oncternal Therapeutics, Inc. Director Stock Options 2,200 20 Jun 2024 Direct
CymaBay Therapeutics, Inc. Director Employee Stock Option (right to buy) 0 22 Mar 2024 Direct

Insider Reports Filed by Robert James Wills

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACOG Alpha Cognition Inc. 14 Jan 2026 2 $0 4 Director 16 Jan 2026, 16:21
ACOG Alpha Cognition Inc. 18 Aug 2025 1 +$127,328 4 Director 21 Aug 2025, 12:36
MIST Milestone Pharmaceuticals Inc. 11 Jul 2025 3 $0 4 Director 15 Jul 2025, 16:15
MIST Milestone Pharmaceuticals Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:19
ACOG Alpha Cognition Inc. 07 Apr 2025 1 $0 4 Director 09 Apr 2025, 21:44
ACOG Alpha Cognition Inc. 07 Apr 2025 0 $0 3 Director 09 Apr 2025, 21:24
MIST Milestone Pharmaceuticals Inc. 28 Aug 2024 1 $0 4 Director 29 Aug 2024, 16:15
/report/000095017024076700-wills-robert-james-2024-06-20 Oncternal Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 16:05
/report/000120919124005283-wills-robert-james-2024-04-08 Oncternal Therapeutics, Inc. 08 Apr 2024 1 +$27,655 4 Director 10 Apr 2024, 20:38
/report/000120919124005154-wills-robert-james-2024-03-28 Oncternal Therapeutics, Inc. 28 Mar 2024 1 +$58,602 4 Director 01 Apr 2024, 19:00
/report/000095017024035448-wills-robert-james-2024-03-22 CymaBay Therapeutics, Inc. 22 Mar 2024 14 $0 4 Director 22 Mar 2024, 16:55
/report/000120919124004015-wills-robert-james-2024-02-23 Oncternal Therapeutics, Inc. 23 Feb 2024 1 -$8,859 4 Director 27 Feb 2024, 17:02
/report/000106299324001422-wills-robert-james-2024-01-24 CymaBay Therapeutics, Inc. 24 Jan 2024 1 $0 4 Director 26 Jan 2024, 18:20
/report/000120919123040282-wills-robert-james-2023-06-28 Oncternal Therapeutics, Inc. 28 Jun 2023 1 $0 4 Director 30 Jun 2023, 16:00
MIST Milestone Pharmaceuticals Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:23
/report/000106299323001496-wills-robert-james-2023-01-25 CymaBay Therapeutics, Inc. 25 Jan 2023 1 $0 4 Director 27 Jan 2023, 15:33
MIST Milestone Pharmaceuticals Inc. 19 Oct 2022 1 +$73,950 4 Director 21 Oct 2022, 19:03
MIST Milestone Pharmaceuticals Inc. 05 Jul 2022 1 $0 4 Director 11 Aug 2022, 18:02
/report/000120919122038033-wills-robert-james-2022-06-16 Oncternal Therapeutics, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 18:00
/report/000106299322001690-wills-robert-james-2022-01-25 CymaBay Therapeutics, Inc. 25 Jan 2022 1 $0 4 Director 27 Jan 2022, 15:51
MIST Milestone Pharmaceuticals Inc. 14 Jun 2021 1 $0 4 Director 29 Jul 2021, 17:34
/report/000120919121036324-wills-robert-james-2021-05-25 Oncternal Therapeutics, Inc. 25 May 2021 1 $0 4 Director 27 May 2021, 18:12